Cramer’s Mad Dash: Eli Lilly

(2:19)

Eli Lilly CEO David Ricks: Projecting 32% total growth for company in 2025

(6:33)

The David Rubenstein Show: Eli Lilly CEO Dave Ricks

(24:7)

David A Ricks, Chair and Chief Executive Officer of Eli Lilly and Company

(45:30)

Buy the weakness in Eli Lilly, says Mizuho Healthcare Strategist Jared Holz

(5:48)

Why Work at Eli Lilly and Company?

(1:21)

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

(9:25)

Cramer’s Mad Dash: Eli Lilly

(2:19)

Flynn: Eli Lilly could capture a significant part of a $100 billion market with Zepbound.

(2:56)

Three-Stock Lunch: Eli Lilly, Transdigm, \u0026 Nvidia

(3:45)

Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage

(4:49)

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

(7:14)

Eli Lilly CEO: We have 11 pipeline projects in obesity

(2:22)

Calls of the Day: Eli Lilly and Netflix

(2:47)

Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline

(1:41)

Eli Lilly: Becoming the world's biggest pharmaceutical company 1876-2024

(2:1econd)

Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

(2:34)

Eli Lilly's drop after earnings is a buying opportunity, says Mizuho's Jared Holz

(5:27)